Neo-Concept International Group Holdings Limited

NCI

$13.41

-0.52%

2026-09-03 16:00:00 EDT-$0.07

Consumer Cyclical

Apparel - Manufacturers

NASDAQ

Active Trading

Neo-Concept International Group Holdings Limited, established in 2021 and headquartered in Kwun Tong, Hong Kong, operates as a comprehensive provider of apparel ...

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Woodside Energy Group (ASX: WDS) (NYSE: WDS):This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824

GuruFocus5/30/2026Neutral

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ

GuruFocus5/29/2026Neutral

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,

Seeking Alpha5/28/2026Neutral

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

GuruFocus•8/25/2026

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Woodside Energy Group (ASX: WDS) (NYSE: WDS):This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,

Neutral

General

NCI: Neutral

Seeking Alpha•5/28/2026

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Neutral

General

NCI: Neutral

Upstream

Neo-Concept Fashion (Zhongshan) Co., Ltd.External Textile & Fabric Suppliers (China-based)Cashmere Yarn Spinners (Inner Mongolia, China)Textile Dyeing & Finishing Mills (Guangdong/China)Logistics & Freight Forwarding Partners (Hong Kong/China)

Downstream

European Brand Owners & Retailers (Private-Label Clientele)North American Brand Owners & Retailers (Private-Label Clientele)Reiss LimitedLes100Ciels Direct-to-Consumer (E-commerce)Les100Ciels Retail Stores (London, UK)Les100Ciels Retail Store (Abu Dhabi, UAE)

Proxies

Shenzhou International Group Holdings LtdHKEx:2313Eclat Textile Co., Ltd.TSE:1476Makalot Industrial Co., Ltd.TSE:1477Crystal International Group LtdHKEx:2330

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Neo-Concept International Group Holdings Limited

Recent News of NCI

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Supply Chain of NCI

Upstream

Downstream

Proxies

Recent News of NCI

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Supply Chain of NCI

Upstream

Downstream

Proxies